Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome

Genes Chromosomes Cancer. 2000 Nov;29(3):276-80. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1035>3.0.co;2-l.

Abstract

The 5q- syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory anemia, deletion of the long arm of chromosome 5, del(5q), as the sole cytogenetic abnormality, and a low frequency of transformation to acute leukemia. Using combined immunophenotyping and fluorescence in situ hybridization (FISH), studies were carried out on bone marrow smears of three 5q- syndrome cases to identify the cell lineages carrying the 5q deletion. In all three cases, the granulocytic, monocytic, and erythroid lineages possessed the del(5q) clonal marker, whereas the T-lymphocytes did not. Interestingly, in one case, cells of B-lymphoid lineage also showed the presence of the del(5q). This is the first report to date showing involvement of an acquired 5q deletion associated with MDS in B-cells. This result suggests that in some cases, MDS arises in a multipotent cell with a capacity to differentiate into both myeloid and lymphoid cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anemia, Refractory / diagnosis
  • Anemia, Refractory / genetics
  • Anemia, Refractory / pathology*
  • B-Lymphocytes / pathology*
  • Biomarkers
  • Bone Marrow Cells / metabolism
  • Bone Marrow Cells / pathology
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 5 / genetics*
  • Female
  • Humans
  • Immunophenotyping* / methods
  • In Situ Hybridization, Fluorescence* / methods
  • Middle Aged
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / pathology*

Substances

  • Biomarkers